Pharmacies are supposed to be knowledgeable regarding the submission of claims to Medicare. Diabetic supplies, such as insulin pumps and insulin used with the pump, should be submitted to Medicare Part B.
Unfortunately, some pharmacies incorrectly submit claims for insulin to Medicare Part D, which results in patients reaching Medicare Part D coverage limits. After a patient reaches the Medicare Part D coverage limit, he or she has to pay out-of-pocket for all prescriptions, including insulin, until the catastrophic limit is reached, as which point benefits resume at 95%. Patients will not prematurely reach the Medicare Part D coverage limit if claims relating to insulin used with insulin pumps are correctly applied to Medicare Part B. Pharmacies generate more revenue when patients pay for prescriptions out-of-pocket.
Levi & Korsinsky LLP is investigating unfair and deceptive business practice claims against pharmacies such as Walgreens, SuperValue, CVS and Albertsons for incorrectly submitting claims for insulin to Medicare Part D.
If you paid out-of-pocket for insulin although you have Medicare Part B, you should learn more about this. Please contact Rosemary M. Rivas, Esq., Levi & Korsinsky LLP, 44 Montgomery Street, Suite 650, San Francisco, CA 94104, Tel. 415-291-2420, Email: email@example.com
The submission of this form does not create an attorney-client relationship automatically. Any information you submit will be maintained as confidential. If Levi & Korsinsky LLP, in its sole discretion, believes that you might have a claim, Levi & Korsinsky LLP will contact you to discuss the matter and whether to establish an attorney client relationship.
No cost, no obligation. Confidential.
Call us at 877-363-5972 or use our form:
Levi & Korsinsky LLP doesn't share your information with others. There is no cost or obligation to submit. Your submission does NOT establish an attorney-client relationship.